Glucose Health, Inc. Board Members Confirm Participation in Preferred Share Conversion at 85% Premium to Market and Introduce New Revenue Growth Strategy
MWN-AI** Summary
On January 7, 2026, Glucose Health, Inc. (OTC: GLUC), a Bentonville, Arkansas-based consumer-health company that specializes in soluble-fiber nutrition products, announced a significant decision by its Board of Directors. All board members holding preferred shares opted to convert their shares into common stock, offering a shareholder-friendly conversion at an impressive 85% premium to the market price. Board member Chris Jemapete emphasized the decision aimed to prioritize available cash for financing the company’s growth initiatives rather than issuing dividends. This move effectively reduced liabilities and streamlined the company's capital structure.
Ned Burke, another board member, outlined a focused strategic plan targeting the expansion of distribution channels, financial growth, and profitability. Notably, Glucose Health has experienced substantial revenue growth, with sales climbing from approximately $291,000 in 2019 to over $1 million by 2022, showcasing a compound annual growth rate of 38.54%. This growth was fueled largely by successful distribution via Amazon, along with recent placements of their flagship product, GlucoDown, in CVS and Walgreens stores.
CEO Mark Schaftlein noted a favorable market response to the board’s conversion decision, highlighted by a sharp increase in the stock price from $0.14 to $0.215—a nearly 54% rise. Glucose Health is keen to capitalize on burgeoning consumer demand by enhancing awareness of its brands. The company's growth strategy includes expanding its soluble-fiber portfolio with new offerings like Fiber Up, which aims to provide improved nutritional benefits in a category of products critical to addressing national public health concerns regarding fiber intake. Overall, Glucose Health, Inc. is positioned for significant future growth in the metabolic wellness space.
MWN-AI** Analysis
Glucose Health, Inc. (OTC: GLUC) has recently made waves in the market following its Board's decision to convert preferred shares at an impressive 85% premium to market prices. This strategic conversion not only alleviates liabilities but also positions the company to prioritize growth over dividends, a significant shift indicative of strong governance and forward-thinking management.
The decision was bolstered by Glucose Health's impressive revenue growth trajectory, with revenues soaring from approximately $291,213 in 2019 to over $1 million in 2022—a compound annual growth rate of 38.54%. This momentum, supported by robust distribution channels through major retailers like CVS and Walgreens, suggests a sustainable growth path. The launch of the Fiber Up brand further enhances their portfolio, as the increasing consumer emphasis on soluble fiber aligns well with public health initiatives.
Market reactions have been positive, with GLUC's stock price rising 54% in recent weeks—a clear indication of investor confidence in the company’s direction. Glucose Health’s capital structure, with only about 10.5 million shares in the public float, enhances potential share appreciation as demand for its products grows.
For investors considering entry into GLUC, current momentum illustrates a strong potential for continued revenue growth bolstered by strategic market positioning and innovations in fiber health solutions. It is advisable to closely monitor the company's execution of its growth initiatives and marketing strategies, particularly in expanding distribution channels and enhancing brand visibility. As public health positions soluble fiber as critical to overall wellness, Glucose Health stands to benefit significantly, making it a compelling prospect for investors looking for exposure in the health and wellness sector.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
BENTONVILLE, Ark., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Glucose Health, Inc. (OTC: GLUC), a consumer-health company specializing in soluble-fiber nutrition products for metabolic support, today confirmed that all members of the Board of Directors holding preferred shares elected to convert their shares, along with all other preferred shareholders, at a shareholder-friendly 85% premium to the market price.
Glucose Health, Inc. Board Member, Chris Jemapete stated: “Some of the preferred series carried dividends with quarterly cash payments to shareholders. In one of our first actions as new Board members, we concluded that cash on hand should be prioritized to finance the future growth of the Company and its national soluble fiber nutrition brands, rather than paying dividends to shareholders, ourselves included.”
Mr. Jemapete further noted: “By converting the preferred shares into common stock, we were able to eliminate a major liability on the Company’s balance sheet and streamline the cap table into a now straightforward structure for financing our planned strategic growth initiatives.”
Glucose Health, Inc. Board Member, Ned Burke added: “We intend to focus our efforts on three main areas: financing growth, increasing the number of distribution channels, and reaching profitability. It is the Board’s clear intention to build a company with strong corporate governance and a complete business structure.”
Mr. Burke further noted: “From 2019 to 2022, Glucose Health, Inc.’s revenues rapidly increased from $291,213 to $1,072,655 – a Compound Annual Growth Rate of 38.54%. The Company achieved this impressive growth with Amazon being its most important distribution channel. Today, in 2026, having achieved national in-store placement of GlucoDown at the nation’s two largest and most respected pharmacy chains, CVS and Walgreens, and with the successful launch of our new fiber supplement brand Fiber Up, the Board is fully committed to achieving even greater revenue growth.”
Glucose Health Inc. CEO, Mark Schaftlein, stated: “Following the Board’s bold actions related to converting the Company’s preferred shares at a premium to market, GLUC’s stock price appreciated from $0.14 on December 22 to a recent closing price of $0.215, an increase of nearly 54%. The Company views the market’s favorable reaction as a clear shareholder and investor vote of confidence in the Board’s decisive steps to support the Company’s outstanding revenue growth potential.”
Mr. Schaftlein further commented: “Glucose Health, Inc. now maintains a capital structure of 27,309,271 issued and outstanding common shares, and just 10,524,984 shares in the public float (shares trading in the open market). In part, due to the high profile of the Company’s fiber nutrition brands at Amazon and leading retailers, the Company estimates its shareholder base now exceeds more than 1,000 individual investors.”
Strategic Revenue Growth
The Company’s strategic revenue growth plan centers on increasing national awareness of its flagship brand for glucose metabolism support, GlucoDown. To date, GlucoDown has garnered nearly 12,000 reviews at Amazon and importantly, the brand has earned top ratings from consumers across every flavor. The Company’s newly launched brand, Fiber Up, positions the Company in the expanding soluble fiber supplement market segment. Fiber Up offers health-conscious consumers both nutritional and taste improvements over traditional fiber supplements. To date, more than 100 clinical studies support the efficacy of the special form of soluble fiber found in both GlucoDown and Fiber Up.
Glucose Health, Inc.’s consumer-healthcare focus on soluble fiber nutrition is fully aligned with national public-health priorities. Dietary fiber has been formally designated a “nutrient of public health concern” by the U.S. Department of Health & Human Services (HHS) and the U.S. Department of Agriculture (USDA)—due to widespread under-consumption across the American population.
Glucose Health, Inc.’s strategic growth plan includes expanding its portfolio of soluble-fiber drink mixes and developing other dietary fiber formats including sodas, waters and nutrition bars. The growth plan aligns the Company fully with the goals of a national public-health initiative and places it at the forefront of consumer demand for metabolic-wellness solutions.
About Glucose Health, Inc.
Glucose Health, Inc. (OTC: GLUC) formulates, manufactures and distributes soluble-fiber nutrition products supporting healthy glucose metabolism and broader metabolic wellness. The Company’s brands—GlucoDown and Fiber Up—are manufactured in the United States and distributed through major national retailers and leading online marketplaces. Glucose Health, Inc. is headquartered in Bentonville, Arkansas.
Contact:Investor Relations888-987-6315info@glucosehealthinc.comwww.glucodown.comwww.fiberup.comOTC: GLUC
FAQ**
What factors influenced the decision by the Board of Directors of Glucose Health Inc. GLUC to convert preferred shares at an 85% premium, and how might this impact investor confidence moving forward?
Given Glucose Health Inc. GLUC's focus on increasing distribution channels, what specific strategies are being employed to enhance partnerships with CVS and Walgreens for the GlucoDown and Fiber Up brands?
How does Glucose Health Inc. GLUC plan to leverage its impressive revenue growth from $291,213 to $1,072,655 to attract new investors and further expand its market presence?
In light of the recent successful launch of Fiber Up, what are the anticipated market trends in soluble fiber nutrition that Glucose Health Inc. GLUC aims to capitalize on in the coming years?
**MWN-AI FAQ is based on asking OpenAI questions about Glucose Health Inc. (OTC: GLUC).
NASDAQ: GLUC
GLUC Trading
0.04% G/L:
$0.48 Last:
27,519 Volume:
$0.4798 Open:
